You are here

P&T® Journal contents for February 2002


Drug Shortages (4-Part Series)
In the first article in this four-part series, Dr. Babinchak discusses the scope and consequences of antimicrobial shortages.
Timothy J. Babinchak, MD
New treatments for gram-positive and gram-negative bacteria, rheumatoid arthritis, and migraine, along with a new antiviral drug for the treatment of HIV-1 infection.
Marvin M. Goldenberg, PhD
Continuing Education Credit
The author provides an overview of anticonvulsants approved during the past 25 years for the treatment and management of seizures.
Gale M. Tucker, PharmD, RPh


David B. Nash, MD, MBA, Editor-in-Chief, goes beyond bar codes to “FindtheDOT.”
David B. Nash, MD, MBA
Drug News
The latest information about approvals, indication changes, industry updates, and news from the FDA.
F. Delbert Moeller, MD, FACOG
Prescription Washington
Stephen Barlas discusses the forthcoming pharmaceutical “Rules of Engagement.”
Stephen Barlas
Drug Forecast
Review of Almotriptan: A 5-HT1B/1D agonist for the treatment of migraine.
Brooke D. Fidler, PharmD
Medication Errors
Matthew Grissinger, RPh, discusses the question of who is to blame for “omission errors.”
Matthew Grissinger, RPh